Akcie - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Aurinia Pharmaceuticals Inc.

AUPH

Valuace

Růst

100

Zdraví

Cena

$ 14.80

--0.02 (-0.13%)

Souhrn

Výkazy

Ukazatele

Profil

Držitelé

Návštěvnost webu

Konkurence

Zprávy společnosti

Kapitalizace

2.0B

Obrat

Zisk

Aktiva

Dluh

ROE

21%

ROA

15%

Cena 1R

7-17

⌀ Cena

11.32

Dividenda

0.0(0.0%)

Čtvrtletní 10-Q

Celoroční 10-K

Nadcházející oznámení zisků

26-02-2026

Poslední dividenda

Profil

Aurinia Pharmaceuticals Inc., biofarmaceutická společnost v komerčním měřítku, se zaměřuje na vývoj a komercializaci terapií pro léčbu různých onemocnění s neuspokojenou lékařskou potřebou ve Spojených státech a mezinárodně. Společnost nabízí LUPKYNIS k léčbě dospělých pacientů s aktivní lupus nephritis. Společnost má spolupráci a licenční smlouvu s Otsuka Pharmaceutical Co., Ltd. Společnost má sídlo ve Victorii v Kanadě.

Sektor

Healthcare

Odvětví

Biotechnology

Počet zaměstnanců

130

Založení

2014-09-03

Adresa

4464 Markham Street

CEO

Peter S. Greenleaf

Web

www.auriniapharma.com

Podobné společnosti

MNKD

MannKind Corporation

$ 5.32

- $ 0.31

HRMY

Harmony Biosciences Holdings, Inc.

$ 31.58

+ $ 0.15

NUVB

Nuvation Bio Inc.

$ 4.64

- $ 0.09

CLDX

Celldex Therapeutics, Inc.

$ 22.78

- $ 0.12

JANX

Janux Therapeutics, Inc.

$ 27.09

+ $ 0.61

VERA

Vera Therapeutics, Inc.

$ 28.27

+ $ 4.08

ABCL

AbCellera Biologics Inc.

$ 3.89

- $ 0.03

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Revenues	283.1	283.1	235.1	175.5	134.0	45.6	50.1	0.3	0.5	0.4	0.2	0.2	0.3	0.9	6.2	0.9	3.4
Cost of Revenues	32.7	32.7	28.2	14.1	5.7	1.1	50.3	52.9	41.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
Gross Profit	250.4	250.4	206.9	161.4	128.4	44.5	-0.2	-52.5	-40.9	0.4	0.2	0.2	0.2	0.9	6.1	0.7	3.4

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	77.1	73.5	70.0	62.5	59.9	67.8	57.2	50.3	45.1	54.5
Cost of Revenues	8.5	8.5	7.1	8.6	5.6	6.0	8.9	7.8	5.4	6.8
Gross Profit	68.6	65.0	62.9	53.9	54.3	61.7	48.3	42.6	39.7	47.7

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
R&D Expenses	0.0	0.0	0.0	49.6	45.0	51.1	50.3	52.9	41.4	33.9	14.5	16.0	9.1	1.9	5.5	3.5	4.0
Selling General & Admin Expenses	0.0	0.0	0.0	195.0	196.4	171.4	96.0	22.2	13.7	12.1	7.0	6.3	6.9	2.2	3.9	2.7	3.3
Depreciation & Amortization	19.4	9.3	19.4	11.6	2.7	2.1	8.1	1.5	1.6	1.5	1.5	1.6	1.5	0.8	0.9	1.0	1.1
Total Operating Expenses	145.5	145.5	211.6	253.1	239.8	225.2	147.6	76.6	56.6	47.5	23.0	23.8	17.5	5.0	11.6	7.2	8.4
Operating Income	104.9	104.9	-4.7	-91.7	-111.5	-180.7	-104.3	-82.5	-56.2	-47.1	-22.8	-23.6	-17.3	-5.5	-5.5	-6.4	-5.0

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	13.6
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	47.8
Depreciation & Amortization	4.9	4.9	4.9	4.9	4.9	4.9	4.8	4.8	4.9	5.5
Total Operating Expenses	35.4	35.2	42.8	32.0	56.0	50.0	49.8	53.2	60.3	64.0
Operating Income	33.2	29.7	20.1	21.8	-1.7	11.7	-1.5	-10.7	-20.6	-16.3

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Income	13.6	13.6	17.0	17.0	5.1	0.5	1.5	2.7	2.2	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0
Interest Expense	8.7	4.3	4.8	2.8	5.1	0.0	0.0	0.0	2.2	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0
Other Expense	9.2	9.2	12.1	14.2	5.1	0.5	1.5	-41.2	-7.9	-23.7	-0.5	4.9	0.6	-2.3	-4.2	4.0	-0.4
IBT	114.2	114.2	7.4	-77.5	-106.4	-180.2	-102.8	-123.7	-64.0	-70.8	-23.3	-18.6	-16.6	-6.4	-9.7	-2.4	-5.5
Income Tax Expense	-173.0	-173.0	1.7	0.6	1.8	0.8	-0.1	0.1	0.1	23.9	0.5	-5.0	0.0	-3.9	0.1	4.0	0.1
Net Income	287.2	287.2	5.8	-78.0	-108.2	-181.0	-102.7	-123.8	-64.1	-70.8	-23.3	-18.6	-16.6	-2.5	-9.7	-2.4	-3.7

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	4.6	2.2	3.2	3.6	4.0	4.3	4.2	4.5	4.6	4.5
Interest Expense	6.5	0.0	1.1	1.1	1.1	1.2	1.2	1.3	1.3	1.4
Other Expense	2.5	2.2	2.1	2.5	2.8	3.1	3.0	0.7	3.3	3.1
IBT	35.7	32.0	22.2	24.3	1.2	14.8	1.5	-10.0	-26.4	-13.1
Income Tax Expense	-175.1	0.4	0.6	1.0	-0.3	0.5	0.8	0.7	0.5	0.3
Net Income	210.8	31.6	21.5	23.3	1.4	14.4	0.7	-10.7	-26.9	-13.4

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
EPS	$0.00	$0.00	$0.00	$-0.54	$-0.76	$-1.40	$-0.87	$-1.33	$-0.76	$-0.92	$-0.66	$-0.58	$-0.57	$-0.40	$-2.74	$-0.70	$-1.44
EPS Diluted	$0.00	$0.00	$0.00	$-0.54	$-0.76	$-1.40	$-0.87	$-1.33	$-0.76	$-0.92	$-0.66	$-0.58	$-0.57	$-0.40	$-2.74	$-0.70	$-1.44
Shares Outstanding	134.4	134.4	143.1	143.2	141.9	129.4	118.5	93.0	84.8	76.9	35.3	32.2	29.2	6.3	3.6	3.5	2.5
Diluted Shares Outstanding	138.7	138.7	146.2	143.2	141.9	129.4	118.5	93.0	84.8	76.9	35.3	32.2	29.2	6.3	3.6	3.5	2.5

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.19	$-0.09
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.19	$-0.09
Shares Outstanding	134.4	137.2	138.9	138.9	142.2	143.1	143.3	144.0	143.8	142.8
Diluted Shares Outstanding	138.7	136.0	143.2	138.9	147.7	145.7	144.1	144.0	143.8	142.8

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash And Equivalents	33.4	83.4	48.9	94.2	231.9	272.4	306.0	118.0	165.6	39.6	5.8	22.7	1.8	0.2	5.9	6.3
Short Term Investments	297.1	275.0	301.6	295.2	234.2	126.0	0.0	7.9	7.8	0.0	10.0	10.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments	330.5	358.5	350.5	389.4	466.1	398.3	306.0	125.9	173.5	39.6	15.8	32.7	1.8	0.2	5.9	6.3
Accounts Receivable	25.5	36.5	24.1	13.5	15.4	1.0	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.1
Inventory	38.9	39.2	39.7	24.8	19.3	13.9	0.0	0.0	-0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0
Other Current Assets	14.8	12.3	10.5	1.3	0.8	6.2	0.0	6.8	1.8	1.7	0.7	0.8	0.2	0.1	1.9	0.1
Total Current Assets	409.7	446.6	424.8	442.5	513.3	419.4	315.1	132.8	175.3	41.4	16.5	33.6	2.1	0.4	8.3	6.6

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	73.2	53.0	66.4	83.4	37.1	33.4	64.5	48.9	46.4	81.7
Short Term Investments	278.6	262.1	246.5	275.0	311.6	297.1	255.5	301.6	291.5	269.0
Total Cash & ST Investments	351.8	315.1	312.9	358.5	348.7	330.5	319.9	350.5	337.9	350.7
Accounts Receivable	30.9	40.1	40.4	36.5	36.5	25.5	28.9	24.1	37.9	19.5
Inventory	44.8	46.5	46.2	39.2	38.7	38.9	39.8	39.7	32.8	33.2
Other Current Assets	11.2	7.2	6.3	12.3	16.5	14.8	9.6	10.5	17.8	12.5
Total Current Assets	438.7	409.0	405.8	446.6	440.5	409.7	398.2	424.8	426.5	415.9

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Property, Plant & Equipment	108.2	98.9	116.6	8.6	9.8	10.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	1.3
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	4.6	4.4	5.0	6.4	8.4	9.3	11.2	12.6	14.1	15.6	17.0	18.5	20.9	3.0	3.2	2.0
Long-Term Investments	0.2	0.0	0.2	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0
Other Long-Term Assets	0.9	0.8	1.5	13.3	11.8	0.2	0.2	0.4	0.4	0.0	0.0	0.3	0.2	0.0	2.2	0.4
Total Long-Term Assets	113.9	104.0	123.3	28.3	30.0	44.2	11.5	13.0	14.6	15.6	17.0	18.8	21.0	3.7	6.0	3.7
Total Assets	523.5	550.6	548.1	470.9	543.4	463.7	326.7	145.9	189.8	57.0	33.6	52.4	23.1	4.2	14.3	10.3

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	84.8	89.5	94.1	98.9	103.5	108.2	112.0	116.6	121.2	125.8
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	3.9	4.0	4.2	4.4	4.5	4.6	4.8	5.0	5.3	5.7
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.0
Other Long-Term Assets	0.1	0.1	0.8	0.8	0.9	0.9	1.5	1.5	1.5	1.5
Total Long-Term Assets	88.8	93.6	99.1	104.0	108.9	113.9	118.4	123.3	128.5	133.0
Total Assets	527.5	502.6	504.9	550.6	549.4	523.5	516.6	548.1	555.0	548.9

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Accounts Payable	8.4	5.2	4.3	3.1	3.9	2.6	4.2	7.1	3.8	2.9	2.1	1.4	1.1	1.2	0.8	0.0
Short-Term Debt	14.9	15.1	31.2	0.9	1.1	0.8	6.9	-0.1	4.1	2.9	0.0	0.0	3.1	0.0	0.0	0.0
Other Current Liabilities	49.2	66.5	36.2	38.9	4.6	7.2	0.1	0.2	0.2	2.0	1.4	1.2	1.6	2.1	0.1	0.9
Current Liabilities	76.9	97.8	77.2	46.1	40.6	32.0	11.3	7.3	8.2	7.9	3.6	2.8	6.0	3.7	2.1	1.3

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	2.2	3.3	4.2	5.2	8.9	8.4	5.7	4.3	8.9	4.8
Short-Term Debt	17.4	17.2	15.5	15.1	15.9	14.9	14.7	31.2	28.6	29.9
Other Current Liabilities	52.0	52.2	44.0	66.5	48.5	48.5	44.3	36.2	31.5	23.5
Current Liabilities	76.2	78.3	68.4	97.8	78.6	76.9	71.1	77.2	73.9	61.7

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Long-Term Debt	71.1	64.3	82.0	7.2	7.7	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Leases	71.1	79.4	97.6	8.1	8.7	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	158.9	173.2	170.1	65.4	64.3	55.9	53.2	33.3	24.1	21.0	13.6	7.3	9.8	6.3	7.9	3.9

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	60.8	64.6	62.4	64.3	71.9	71.1	73.8	82.0	78.9	86.2
Capital Leases	0.0	81.8	77.9	79.4	87.9	86.0	73.8	82.0	93.2	101.2
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	161.8	167.3	154.7	173.2	161.4	158.9	157.2	170.1	163.1	156.6

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Common Stock	1,205.6	1,187.7	1,200.2	1,185.3	1,177.1	944.3	790.5	504.7	499.2	299.8	261.6	258.5	207.1	204.7	0.0	0.0
Retained Earnings	-952.3	-936.6	-942.3	-864.3	-756.1	-575.2	-539.8	-416.0	-351.8	-281.0	-257.8	-236.4	-205.4	-217.1	-202.0	-203.8
Comprehensive Income	-0.9	-0.6	-0.7	-1.1	-0.9	-0.8	-0.8	-0.8	-0.9	-0.8	-0.8	-0.8	-4.8	-10.9	-10.2	-9.8
Total Common Equity	364.6	377.5	378.0	405.4	479.1	407.8	273.5	112.6	165.7	36.0	20.0	45.1	13.3	-2.1	6.4	6.3

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	1,116.8	1,122.6	1,163.3	1,187.7	1,206.6	1,205.6	1,208.0	1,200.2	1,198.6	1,196.5
Retained Earnings	-860.2	-891.7	-913.2	-936.6	-938.0	-952.3	-953.1	-942.3	-915.4	-902.0
Comprehensive Income	-0.7	-0.9	-0.8	-0.6	-0.4	-0.9	-0.9	-0.7	-0.9	-1.0
Total Common Equity	365.8	335.3	350.2	377.5	388.0	364.6	359.5	378.0	391.9	392.3

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Debt		86.0	79.4	97.6	8.1	8.7	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Book Value		364.6	377.5	378.0	405.4	479.1	407.8	273.5	112.6	165.7	36.0	20.0	45.1	13.3	-2.1	6.4	6.3

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		365.8	335.3	350.2	377.5	388.0	364.6	359.5	378.0	391.9	392.3

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Income	-50.3	287.2	5.8	-78.0	-108.2	-181.0	-102.7	-123.8	-64.1	-70.8	-23.3	-18.6	-16.6	-2.5	-9.7	-2.4	-5.6
Depreciation & Amortization	19.9	9.3	19.4	11.6	2.7	2.8	1.4	1.5	1.6	1.5	1.5	1.6	1.5	0.8	0.9	1.0	1.1
Stock-Based Compensation	37.9	14.7	31.6	45.3	32.3	31.2	17.5	7.4	6.9	4.2	1.4	3.2	2.2	0.2	0.3	0.4	0.0
Change Working Capital	0.7	-8.8	5.4	-5.6	-6.8	-21.6	4.5	2.1	-6.0	1.7	1.5	1.2	-2.2	1.0	2.7	-0.3	-0.9
Change In Accounts Receivable	-5.8	-4.9	-12.5	-10.6	1.9	-15.4	-13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	-0.2	0.4
Change In Accounts Payable	12.3	-1.9	0.9	13.4	0.7	4.1	13.6	0.0	0.0	0.0	0.0	0.9	-1.5	1.1	2.5	0.0	0.0
Change In Inventories	-6.4	-6.5	0.5	-15.9	-9.1	-5.6	-13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	39.8	9.5	-17.9	-6.8	0.5	10.9	9.5	8.2	0.1	-1.8	2.0	0.0	1.1	-0.1	-4.8	4.5	1.0
Cash from Operations	-1.2	0.0	0.0	-33.5	-79.5	-157.7	-69.9	-63.5	-51.6	-41.2	-18.7	-17.8	-16.9	-4.5	-6.5	-1.4	-4.3

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	210.8	31.6	21.5	23.3	1.4	14.4	0.7	-10.7	-26.9	-13.4
Depreciation & Amortization	4.9	4.9	4.9	4.9	4.9	4.9	4.8	4.8	4.9	5.3
Stock-Based Compensation	0.0	5.9	5.4	-3.4	8.9	8.3	8.6	5.7	11.8	11.8
Change Working Capital	6.7	6.1	5.7	-25.0	22.5	-11.4	5.1	-10.8	19.6	-13.9
Change In Accounts Receivable	-10.8	9.4	0.3	-3.8	-0.1	-11.0	3.4	-4.8	14.1	-18.4
Change In Accounts Payable	1.1	0.0	-0.9	-1.0	-0.1	-3.2	2.7	1.3	1.4	10.6
Change In Inventories	-0.8	1.7	-0.3	-7.0	-0.5	0.1	0.9	-0.1	-6.7	-0.6
Other Non-cash Items	-1.2	-3.9	6.7	1.5	-7.6	0.9	-3.4	-7.7	18.3	-0.7
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	-13.3

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2011	2010
Capital Expenditure	0.0	-0.3	-0.3	-0.7	-0.3	-1.5	-7.3	-0.1	-0.1	0.0	0.0	-0.1	-0.1	-0.1	-1.2	-0.1
Acquisitions	0.0	0.0	0.0	0.0	0.0	-1.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	-576.6	-526.7	-545.8	-523.5	-524.0	-439.0	-203.0	0.0	-36.1	-98.0	-21.1	-20.0	-10.0	0.0	0.0	0.0
Sales of Investment	561.2	494.1	585.4	529.4	464.3	354.4	52.1	7.9	36.1	90.0	31.1	20.0	0.0	0.0	0.0	0.0
Other Investing Activities	49.3	0.0	0.0	-11.9	-0.7	-16.6	-1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6
Cash from Investing	-15.4	0.0	0.0	-6.7	-60.6	-103.9	-158.2	7.8	-0.1	-8.0	10.0	0.0	-10.1	0.0	-1.2	1.5

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-0.1	-0.1	-0.1	0.0	-0.3	0.1	-0.1	0.0	0.0	0.1
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	-289.2	0.0	-145.4	-92.0	-84.7	-143.0	-196.9	-121.3	-138.0	-122.8
Sales of Investment	238.8	0.0	132.3	123.0	124.0	132.6	158.4	170.5	131.7	103.0
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-6.2	-19.7

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Debt Repaid	-12.5	0.0	0.0	-10.0	0.0	0.0	0.0	-0.1	0.0	0.0	0.0	0.0	-1.6	0.0	0.0	0.0	0.0
Debt Issued	-2.7	79.4	-18.2	99.5	-0.7	0.3	8.4	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0
Issuance of Common Stock	3.2	0.0	0.0	0.0	2.4	196.7	187.7	223.1	0.0	0.0	0.0	0.0	48.3	5.9	0.8	2.3	0.0
Repurchase of Common Stock	-18.3	-98.2	-40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	-9.3	0.0	0.0	4.9	0.0	24.4	6.6	20.7	4.0	175.2	42.6	0.8	1.2	0.4	0.0	0.0	4.6
Cash from Financing	-31.0	0.0	0.0	-5.1	2.4	221.1	194.4	243.7	4.0	175.2	42.6	0.8	47.9	6.2	0.7	2.3	4.6

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-6.5	0.0
Debt Issued	78.2	-3.6	3.9	-1.5	-8.5	1.9	-2.6	-9.1	10.9	-8.0
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2
Repurchase of Common Stock	1.3	-9.0	-42.6	-46.9	-21.8	0.0	-6.1	-12.3	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	-3.5
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-5.5	-2.3

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Change in Cash		-48.3	-3.2	34.6	-45.3	-137.7	-40.5	-33.7	188.1	-47.7	126.0	33.9	-17.0	20.9	1.6	-5.9	-0.3	1.5
Closing Cash Balance		33.4	80.2	83.4	48.9	94.2	231.9	272.4	306.0	118.0	165.6	39.6	5.8	22.7	1.8	0.2	5.9	6.3

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		7.0	20.2	-13.4	-17.0	46.3	3.7	-31.1	15.6	2.5	-35.3
Closing Cash Balance		80.2	73.2	53.0	66.4	83.4	37.1	33.4	64.5	48.9	46.4

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Free Cash Flow		-1.2	135.4	44.1	-34.2	-79.8	-159.2	-77.2	-63.6	-51.7	-41.2	-18.7	-17.8	-17.0	-4.6	-6.6	-2.5	-4.4
Real Free Cash Flow		-39.1	120.7	12.5	-79.5	-112.1	-190.4	-94.7	-71.0	-58.5	-45.4	-20.1	-21.0	-19.2	-4.9	-6.9	-2.9	-4.4

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		44.5	44.4	44.1	1.3	30.1	16.9	15.7	-18.6	14.8	-13.2
Real Free Cash Flow		44.5	38.5	38.7	4.7	21.1	8.6	7.1	-24.3	3.0	-25.0

Nacenění

Finance

Efektivita

Marže

Dividenda

Ostatní

Nacenění

Ukazatel	Aktuální	Historické	Konkurence
P/E	6.8	-5.2	-1.4
P/S	6.9	1267.1	9.4
P/B	5.3	4.2	5.2
P/FCF	15.4	-12.3	-1.5
Market cap	$2.0	$1.2

P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel	Aktuální	Historické	Srovnání
Debt to Assets	14.8 %	2.9 %	0 %
Debt to Income	27.2 %	-12 %	0 %
Debt to Free cash flow	61.9 %	-3145.4 %	0 %
Interest expense percentage	8.3 %	-4.2 %	44.7 %
Current ratio	5.8	10.6	0